Gene · 2591
GALNT3: polypeptide N-acetylgalactosaminyltransferase 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. GALNT3: polypeptide N-acetylgalactosaminyltransferase 3. Genes, record 2591. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2591
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q14435 | Polypeptide N-acetylgalactosaminyltransferase 3 | 633 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents25
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 69248 | Q14435 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 11350 | Q14435 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1675 | Q14435 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1675 | Q14435 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 11350 | Q14435 | Espacenet |
| WO 2025093745 A1 | 2025-05-08 | 164 | Q14435 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 28852 | Q14435 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 28852 | Q14435 | Espacenet |
| US 12006548 B2 | 2024-06-11 | 333 | Q14435 | Espacenet |
| JP 2023058610 A | 2023-04-25 | 28852 | Q14435 | Espacenet |
1 to 10 of 25
See all 25 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants521
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | GALNT3 papers | Newest fiscal year |
|---|---|---|---|
| ZIADE000649 | Skeletal Disorders and Mineral Homeostasis Section | 8 | 2025 |
| P30CA036727 | Buffett Cancer Center Support Grant | 5 | 2025 |
| R01AR041398 | Novel Molecular Biomarkers of Bone Microarchitecture | 5 | 2025 |
| R01CA200423 | Chemical Glycoproteomics | 5 | 2025 |
| P20GM109036 | Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases | 4 | 2025 |
| U19AG055373 | Trans-omics Integration of Multi-omics Studies for Osteoporosis | 4 | 2025 |
| ZIADE000713 | Role of O-glycosylation in Animal Development | 4 | 2025 |
| ZIADE000739 | Structure and Function of UDP-GalNAc:polypeptide alpha-GalNAc transferases | 3 | 2025 |
| P30AR072581 | Indiana Core Center for Clinical Research in Musculoskeletal Health | 2 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 521Source NIH's project files
See all 521 nih grantsPapers840
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fibroblast growth factor 23 (FGF23): From synthesis to cleavage. | Mol Cell Endocrinol | 2027 | 42697502 | PubTator, text mining | PubMed |
| A Novel Homozygous GALNT3 Deletion in Hyperphosphatemic Familial Tumoral Calcinosis Presenting with Subcutaneous Calcifications and Raynaud's Phenomenon in an Adult Patient: A Case Report. | Mol Syndromol | 2026 | 42569695 | PubTator, text mining | PubMed |
| Mechanistic insights into mutations that cause diseases of phosphate dysregulation. | Proc Natl Acad Sci U S A | 2026 | 42555639 | PubTator, text mining | PubMed |
| Integrating Proteome-Wide Association Studies and Single-Cell Transcriptomics Identifies GSTT2B as a Causal Mediator and Prioritizes COL4A1 in Diabetic Retinopathy. | Int J Mol Sci | 2026 | 42511522 | PubTator, text mining | PubMed |
| APOA1, DEFB103A_DEFB103B and DSG3 Are Novel Circulating Biomarkers of Psoriasis. | Int J Mol Sci | 2026 | 42450078 | PubTator, text mining | PubMed |
| When X Does Not Mark the Spot: Autosomal Dominant and Recessive Forms of Renal Hypophosphatemic Rickets and Osteomalacia. | Curr Osteoporos Rep | 2026 | 42412262 | PubTator, text mining | PubMed |
| Disentangling adiposity-related and non-adiposity-related genetic pathways for type 2 diabetes. | medRxiv | 2026 | 42396322 | PubTator, text mining | PubMed |
| Research progress in the role and mechanism of GALNT3 in human diseases (Review). | Biomed Rep | 2026 | 41993969 | PubTator, text mining | PubMed |
| Clinical and Functional Characterization of Novel GALNT3 Mutations in a Chinese Child with Hyperphosphatemic Familial Tumoral Calcinosis. | Int J Mol Sci | 2026 | 41898628 | PubTator, text mining | PubMed |
| Retraction Note: LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway. | J Exp Clin Cancer Res | 2026 | 41888917 | PubTator, text mining | PubMed |
1 to 10 of 840
See all 840 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2591
GET https://conductscience.org/api/genes/v1/2591/patents?page=2